Wayne Winegarden Healthcare News

This is selected healthcare news for Wayne Winegarden, which is filed under People. There are 39 news items for this page. A press release filter page is also available for Wayne Winegarden.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
10/27/2022 Project Homekey is expensive and ineffective. Let's shift to much more promising policies.
By Kerry Jackson & Wayne Winegarden Last month, San Diego officials announced that the county and city will be receiving nearly $12 million in state Project Homekey funds to build housing for the homeless. It's a publicly funded program that will, no doubt, be celebrated in the halls of government ...
pacificresearch.org
9/26/2022 New poll numbers counteract DC progressive push on Medicare for All
... the healthcare system through Medicare for All would eliminate the health insurance coverage that not only most Americans have, but are overwhelmingly satisfied with,‚Au Wayne Winegarden, senior fellow in business and economics at PRI, said in an email response to the Northern California Record. ‚AuMedicare for All is a ...
norcalrecord.com
9/16/2022 Is this PBM tactic blocking healthcare access?
... they are dispensed, with the initial goals of preventing unnecessary utilization of biopharmaceuticals and decreasing healthcare spending. However, a study conducted by Robert Popovian and Wayne Winegarden investigating the impact of prior authorizations has demonstrated that such schemes increase overall healthcare spending by at least $1.9 billion, primarily imposing these ...
pioneerinstitute.org
9/13/2022 Humira biosimilar savings may face delays
... lower-cost biosimilars. ‚AuThe system is so addicted to having rebates offsetting costs and lowering premiums that it becomes a barrier to competition,‚Au said Wayne Winegarden, director of the Pacific Research Institute's Center for Medical Economics and Innovation, a California-based nonpartisan think tank. ‚AuEven though biosimilars have ...
Modern Healthcare
8/23/2022 New Report: Biosimilars Save Patients Over $11 Billion Annually, Fixing Broken System Would Help Patients Save More
... Research Institute . Continue Reading Pacific Research Institute "Patients living with cancer, autoimmune diseases, osteoporosis, and other illnesses are receiving revolutionary treatment from biologics," said Dr. Wayne Winegarden , the Center director and the study's author. "As our research shows, patients and the health care system are experiencing over $11 billion in ...
PR Newswire
8/20/2022 Government to Stop Paying for COVID Vaccines
The government plans to stop paying for COVID treatment. This will push the cost to patients and insurers. NTD spoke with Wayne Winegarden, senior fellow at the Pacific Research Institute, who says COVID-19 will be with us for a long time, so COVID treatment should be incorporated into the ...
ntd.com
4/28/2022 New Brief: Broken System Imposes Higher Out-of-Pocket Costs on Patients, Puts Interests of Government and Insurers First
... prioritize the needs of patients, but our broken third-party payment system caters to insurers and government as the largest payers of care," said Dr. Wayne Winegarden , director of PRI's Center for Medical Economics and Innovation and the series author. "As a result, government and insurance companies are exerting greater ...
PR Newswire
8/3/2021 New Study: Creating Two-Part Drug Pricing System Would Ensure Prices More Accurately Reflect How Patients Value Drugs
... central planners can only impose price controls that don't accurately estimate how 300 million Americans value the benefits from new and innovative medicines," said Dr. Wayne Winegarden , director of PRI's Center for Medical Economics and Innovation and the brief's author. Value assessment frameworks, such as the one used by the ...
PR Newswire
7/28/2021 Why Should We Rescue The Legislative Intent Of The BPCIA?
By Peter J. Pitts, Robert Popovian, and Wayne Winegarden What happens when regulatory ambiguity displaces sound scientific guidance, deterring the legislative intent of Congress? This is precisely the situation regarding the FDA changing the regulatory rules of the road regarding a biosimilar's strength versus its potency. It is a ...
bioprocessonline.com
3/25/2021 Robert Popovian, Wayne Winegarden: We Need Greater Transparency to Improve America's Health Care System | Columnists
... most vital health care reform is transparency. Source Opposition to transparency is a bane to meaningful health care financing reform. News Highlights Health Robert Popovian, Wayne Winegarden: We Need Greater Transparency to Improve America's Health Care System Columnists Check all news and articles from the Health news information updates ...
bollyinside.com
3/17/2021 ICER Analyses Are Flawed, Undervalue Life-Saving Medicines, and are Biased Toward Price Controls, Finds New PRI Brief
... Cost effectiveness reports may provide precise estimates, but there is no reason to believe that these estimates accurately reflect the value of medicines," said Dr. Wayne Winegarden , the brief's author. "The documented biases in their value assessments should raise serious concerns that ICER's work is inaccurate and biased toward undervaluing ...
Yahoo News
12/10/2020 New Brief: Tearing Down Drug 'Rebate Walls' Would Save Patients, Improve Health Care Outcomes
... Research Institute "America's patients are harmed because they do not benefit from large, fast-growing rebates when purchasing their medicines," writes the brief's author, Dr. Wayne Winegarden , director of PRI's Center for Medical Economics and Innovation. "When rebate walls block competition, they impose excessive costs on patients, block access to ...
PR Newswire
8/25/2020 Pacific Research Institute
... suggesting that electric vehicles tax-credits are regressive, that “disproportionately subsidizes wealthy buyers,""has been repeated ad nauseum is typically attributed to a report by Wayne Winegarden of the Pacific Research Institute." The figure has been used in numerous articles which are in opposition to actions combatting climate change. The ...
sourcewatch.org
8/24/2020 Surprise Billing Price Controls Decreasing Care Quality in CA
... consolidation in the state. “California's surprise medical billing law has created unintended consequences that are increasing healthcare costs and reducing quality,” stated the brief's author Wayne Winegarden, PhD, director of PRI's Center for Medical Economics and Innovation. “Price controls have led to fewer doctors on call in emergency rooms, and ...
RevCycle Intelligence
8/3/2020 New federal relief bill includes liability protections during COVID-19 pandemic; ‘An important improvement to the litigation landscape’ | Northern California Record
... any legal action. “The HEALS Act increases the cost of filing a frivolous lawsuit, while still protecting the right of plaintiffs to bring meritorious litigation,” Wayne Winegarden, Ph.D., senior fellow in business and economics at the Pacific Research Institute, told the Northern California Record by email. “By striking a better ...
norcalrecord.com
7/16/2020 ESG Investing Should Remain An Individual Choice
... laudable, many analysts find that “portfolios with a purpose” often represent a lower-value proposition from traditional investment strategies. According to a study by Dr. Wayne Winegarden with the Pacific Research Institute , ESG investing produced 43.9 percent less in returns than investments in standard S&P 500 index funds. Even ...
Forbes
7/2/2020 New Study: Medical Innovation Relies on Elected Officials Embracing Health Care Entrepreneurship
... have seen how beneficial health care technology can be in providing high quality care during the COVID-19 crisis at a reasonable cost,” said Dr. Wayne Winegarden , author of the study. “But soon, we'll go back to the status quo and if an entrepreneur comes up with a more effective ...
Health IT Answers
6/25/2020 New Study: Future Medical Innovation Will Be Hindered Unless Elected Officials Embrace Health Care Entrepreneurship
... have seen how beneficial health care technology can be in providing high quality care during the COVID-19 crisis at a reasonable cost," said Dr. Wayne Winegarden , author of the study. "But soon, we'll go back to the status quo and if an entrepreneur comes up with a more effective ...
PR Newswire
6/25/2020 New Study: Future Medical Innovation Will Be Hindered Unless Elected Officials Embrace Health Care Entrepreneurship
... have seen how beneficial health care technology can be in providing high quality care during the COVID-19 crisis at a reasonable cost," said Dr. Wayne Winegarden , author of the study. "But soon, we'll go back to the status quo and if an entrepreneur comes up with a more effective ...
BioSpace
3/25/2020 New Animated Series Aims to Help Patients "Escape the Drug Pricing Maze"
... These ideas have been amplified during our current coronavirus pandemic. While these proposals may sound good, they would harm America's patients in practice," said Dr. Wayne Winegarden , director of PRI's Center for Medical Economics and Innovation. In the "Escape the Drug Pricing Maze" series, Professor Salvare guides Pete Paystoomuch through ...
PR Newswire
3/10/2020 Study: Expanding biosimilar use could reduce patient costs
... Research Institute. "Biologics effectively treat very serious illnesses but can often be very expensive and lead to patients incurring significant out-of-pocket costs," said Wayne Winegarden, director of PRI's Center for Medical Economics and Innovation and the brief's author. "Our new study shows that if more patients were able ...
drugstorenews.com
3/10/2020 New Study: Expanding Biosimilars Use Could Save Patients, Reduce Out-of-Pocket Costs by 17 Percent
... study. "Biologics effectively treat very serious illnesses but can often be very expensive and lead to patients incurring significant out-of-pocket costs," said Dr. Wayne Winegarden , director of PRI's Center for Medical Economics and Innovation and the brief's author. "Our new study shows that if more patients were able ...
BioSpace
3/10/2020 New Study: Expanding Biosimilars Use Could Save Patients, Reduce Out-of-Pocket Costs by 17 Percent
... study. "Biologics effectively treat very serious illnesses but can often be very expensive and lead to patients incurring significant out-of-pocket costs," said Dr. Wayne Winegarden , director of PRI's Center for Medical Economics and Innovation and the brief's author. "Our new study shows that if more patients were able ...
PR Newswire
3/10/2020 New Study: Expanding Biosimilars Use Could Save Patients, Reduce Out-of-Pocket Costs by 17 Percent
... study. "Biologics effectively treat very serious illnesses but can often be very expensive and lead to patients incurring significant out-of-pocket costs," said Dr. Wayne Winegarden , director of PRI's Center for Medical Economics and Innovation and the brief's author. "Our new study shows that if more patients were able ...
Yahoo News
1/8/2020 Reforming Supply Chain & Drug Pricing System Will Lower Health Care Costs, Not Price Caps & Regulations Pushed by Washington
... Economics and Innovation Media Alert "Politicians are promoting drug price caps and increased regulation in a futile attempt to increase health care affordability," said Dr. Wayne Winegarden , director of PRI's Center for Medical Economics and Innovation and the brief's author. "Experiences worldwide have shown that more government control will worsen ...
PR Newswire